Acadian Asset Management LLC Has $1.56 Million Stock Holdings in Ultralife Co. (NASDAQ:ULBI)

Acadian Asset Management LLC raised its holdings in shares of Ultralife Co. (NASDAQ:ULBIFree Report) by 4.4% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 146,635 shares of the technology company’s stock after purchasing an additional 6,206 shares during the quarter. Acadian Asset Management LLC owned approximately 0.88% of Ultralife worth $1,556,000 at the end of the most recent reporting period.

Several other hedge funds have also added to or reduced their stakes in ULBI. Victory Capital Management Inc. acquired a new stake in shares of Ultralife during the fourth quarter worth $59,000. O Shaughnessy Asset Management LLC acquired a new stake in shares of Ultralife during the first quarter worth $100,000. Rhumbline Advisers lifted its holdings in shares of Ultralife by 1,728.3% during the second quarter. Rhumbline Advisers now owns 11,811 shares of the technology company’s stock worth $125,000 after buying an additional 11,165 shares in the last quarter. Perritt Capital Management Inc. lifted its holdings in shares of Ultralife by 25.0% during the first quarter. Perritt Capital Management Inc. now owns 15,000 shares of the technology company’s stock worth $132,000 after buying an additional 3,000 shares in the last quarter. Finally, D.A. Davidson & CO. acquired a new stake in shares of Ultralife during the fourth quarter worth $163,000. Institutional investors and hedge funds own 30.68% of the company’s stock.

Ultralife Stock Up 2.0 %

Shares of NASDAQ ULBI opened at $9.55 on Monday. The company has a debt-to-equity ratio of 0.07, a quick ratio of 2.06 and a current ratio of 4.07. Ultralife Co. has a 52 week low of $6.36 and a 52 week high of $13.39. The stock has a market capitalization of $158.72 million, a P/E ratio of 14.92 and a beta of 0.98. The stock’s fifty day moving average is $10.54 and its 200 day moving average is $10.37.

Ultralife (NASDAQ:ULBIGet Free Report) last issued its quarterly earnings results on Thursday, July 25th. The technology company reported $0.22 EPS for the quarter, topping analysts’ consensus estimates of $0.14 by $0.08. Ultralife had a return on equity of 9.32% and a net margin of 5.96%. The company had revenue of $42.98 million for the quarter.

Analysts Set New Price Targets

ULBI has been the subject of a number of research reports. Benchmark lifted their target price on Ultralife from $13.00 to $14.00 and gave the stock a “buy” rating in a report on Thursday, June 27th. StockNews.com upgraded Ultralife from a “buy” rating to a “strong-buy” rating in a research report on Monday, August 12th.

Get Our Latest Stock Analysis on ULBI

Ultralife Profile

(Free Report)

Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.

See Also

Institutional Ownership by Quarter for Ultralife (NASDAQ:ULBI)

Receive News & Ratings for Ultralife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ultralife and related companies with MarketBeat.com's FREE daily email newsletter.